Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018
PsiquiatriaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- JAMA
- Publicado em
- 13 jul 2021
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018
Medicaid Outcomes Distributed Research Network (MODRN), Julie M Donohue, Marian P Jarlenski, Joo Yeon Kim, Lu Tang, Katherine Ahrens, Lindsay Allen, Anna Austin, Andrew J Barnes, Marguerite Burns et al.
Descritores MeSH
- Narcotic Antagonists
- Opioid-Related Disorders
- Opiate Substitution Treatment
- Buprenorphine
- Child
- Cross-Sectional Studies
- Female
- Humans
- Male
- Medicaid
Veja também
Estudos relacionados
- Systematic review and meta-analysis of retention in treatment using medications for opioid use disorder by medication, race/ethnicity, and gender in the United States
- Buprenorphine-based treatments outcomes in pregnant opioid-dependent women: A systematic review and meta-analysis
- Low-dose Buprenorphine Initiation in Pregnancy: A Systematic Review
- The impact of cannabis on non-medical opioid use among individuals receiving pharmacotherapies for opioid use disorder: a systematic review and meta-analysis of longitudinal studies